Agency Information Collection Activities: Proposed Collection; Comment Request, 65170 [2019-25647]

Download as PDF 65170 Federal Register / Vol. 84, No. 228 / Tuesday, November 26, 2019 / Notices all U.S. and foreign patents and applications claiming priority to any member of the above. The patent rights in these inventions have been assigned or exclusively licensed to the Government of the United States of America. The prospective exclusive license territory may be worldwide and in fields of use that may be limited to human therapeutics for (1) X-linked juvenile retinoschisis and (2) schisis cavity associated ocular disease or injury. The aforementioned patent estates cover inventions directed to gene therapy and specifically, expression vectors and therapeutic methods of using such vectors in the treatment of ocular diseases resulting from failure to produce or the defective production of an ocular protein. This invention is also directed to methods of administering expression vectors capable of modulating a target gene or gene product for the treatment of ocular disease. This notice is made in accordance with 35 U.S.C. 209 and 37 CFR part 404. The prospective exclusive license will be royalty bearing. The prospective exclusive license may be granted unless within thirty ( ) days from the date of this published notice, the National Heart, Lung, and Blood Institute receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR part 404. In response to this Notice, the public may file comments or objections. Comments and objections, other than those in the form of a license application, will not be treated confidentially, and may be made publicly available. License applications submitted in response to this notice will be presumed to contain business confidential information and any release of information in these license applications will be made only as required and upon a request under the Freedom of Information Act, 5 U.S.C. 552. Dated: November 21, 2019. Michael A. Shmilovich, Senior Licensing and Patenting Manager, National Heart, Lung, and Blood Institute. [FR Doc. 2019–25685 Filed 11–25–19; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 16:47 Nov 25, 2019 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: 2020–2023 National Survey on Drug Use and Health: Methodological Field Tests (OMB No. 0930–0290)—Extension The National Survey on Drug Use and Health (NSDUH) is a survey of the U.S. civilian, non-institutionalized population aged 12 years old or older. The data are used to determine the prevalence of use of tobacco products, alcohol, illicit substances, and illicit use of prescription drugs. The results are used by SAMHSA, the Office of National Drug Control Policy (ONDCP), federal government agencies, and other organizations and researchers to establish policy, direct program activities, and better allocate resources. Methodological tests will continue to be designed to examine the feasibility, quality, and efficiency of new procedures or revisions to existing survey protocol. Specifically, the tests will measure the reliability and validity of certain questionnaire sections and items through multiple measurements on a set of respondents; assess new methods for gaining cooperation and PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 participation of respondents with the goal of increasing response and decreasing potential bias in the survey estimates; and assess the impact of new sampling techniques and technologies on respondent behavior and reporting. Research will involve focus groups, cognitive laboratory testing, customer satisfaction surveys, and field tests. These methodological tests will continue to examine ways to increase data quality, lower operating costs, and gain a better understanding of sources and effects of nonsampling error on NSDUH estimates. Particular attention will be given to minimizing the impact of design changes so survey data continue to remain comparable over time. If these tests provide successful results, current procedures or data collection instruments may be revised. The number of respondents to be included in each field test will vary, depending on the nature of the subject being tested and the target population. However, the total estimated response burden is 8,225 hours. The exact number of subjects and burden hours for each test are unknown at this time, but will be clearly outlined in each individual submission. These estimated burden hours are distributed over three years as follows: TABLE 1—ESTIMATED BURDEN FOR NSDUH METHODOLOGICAL FIELD TESTS Time period Respondent burden hours May 2020 to May 2021 ........ May 2021 to May 2022 ........ May 2022 to May 2023 ........ 2,742 2,742 2,741 Total ............................... 8,225 Send comments to Summer King, SAMHSA Reports Clearance Officer, 5600 Fishers Lane, Room 15E57–B, Rockville, Maryland 20857, OR email a copy to summer.king@samhsa.hhs.gov. Written comments should be received by January 27, 2020. Summer King, Statistician. [FR Doc. 2019–25647 Filed 11–25–19; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–6190–N–01] Notice of Intent To Close Reno Field Office Office of Field Policy and Management, HUD. AGENCY: E:\FR\FM\26NON1.SGM 26NON1

Agencies

[Federal Register Volume 84, Number 228 (Tuesday, November 26, 2019)]
[Notices]
[Page 65170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25647]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed projects 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer on (240) 276-1243.
    Comments are invited on: (a) Whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Proposed Project: 2020-2023 National Survey on Drug Use and Health: 
Methodological Field Tests (OMB No. 0930-0290)--Extension

    The National Survey on Drug Use and Health (NSDUH) is a survey of 
the U.S. civilian, non-institutionalized population aged 12 years old 
or older. The data are used to determine the prevalence of use of 
tobacco products, alcohol, illicit substances, and illicit use of 
prescription drugs. The results are used by SAMHSA, the Office of 
National Drug Control Policy (ONDCP), federal government agencies, and 
other organizations and researchers to establish policy, direct program 
activities, and better allocate resources.
    Methodological tests will continue to be designed to examine the 
feasibility, quality, and efficiency of new procedures or revisions to 
existing survey protocol. Specifically, the tests will measure the 
reliability and validity of certain questionnaire sections and items 
through multiple measurements on a set of respondents; assess new 
methods for gaining cooperation and participation of respondents with 
the goal of increasing response and decreasing potential bias in the 
survey estimates; and assess the impact of new sampling techniques and 
technologies on respondent behavior and reporting. Research will 
involve focus groups, cognitive laboratory testing, customer 
satisfaction surveys, and field tests.
    These methodological tests will continue to examine ways to 
increase data quality, lower operating costs, and gain a better 
understanding of sources and effects of nonsampling error on NSDUH 
estimates. Particular attention will be given to minimizing the impact 
of design changes so survey data continue to remain comparable over 
time. If these tests provide successful results, current procedures or 
data collection instruments may be revised.
    The number of respondents to be included in each field test will 
vary, depending on the nature of the subject being tested and the 
target population. However, the total estimated response burden is 
8,225 hours. The exact number of subjects and burden hours for each 
test are unknown at this time, but will be clearly outlined in each 
individual submission. These estimated burden hours are distributed 
over three years as follows:

     Table 1--Estimated Burden for NSDUH Methodological Field Tests
------------------------------------------------------------------------
                                                            Respondent
                       Time period                         burden hours
------------------------------------------------------------------------
May 2020 to May 2021....................................           2,742
May 2021 to May 2022....................................           2,742
May 2022 to May 2023....................................           2,741
                                                         ---------------
    Total...............................................           8,225
------------------------------------------------------------------------

    Send comments to Summer King, SAMHSA Reports Clearance Officer, 
5600 Fishers Lane, Room 15E57-B, Rockville, Maryland 20857, OR email a 
copy to [email protected]. Written comments should be received 
by January 27, 2020.

Summer King,
Statistician.
[FR Doc. 2019-25647 Filed 11-25-19; 8:45 am]
 BILLING CODE 4162-20-P